US · SRDX
Surmodics, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Eden Prairie, MN 55344-3523
- Website
- surmodics.com
Price · as of 2024-09-30
—
Market cap 393.83M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $130.16 | — |
| Intrinsic Value(DCF) | $16.12 | — |
| Graham-Dodd Method(GD) | $1.17 | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | $10.32 | $44.98 | $1.70 | $2.35 | $39.36 |
| 2011 | $12.60 | $31.79 | $1.58 | $4.22 | $0.00 |
| 2012 | $20.06 | $47.42 | $2.73 | $7.96 | $0.00 |
| 2013 | $23.84 | $163.94 | $3.53 | $11.18 | $16.55 |
| 2014 | $22.03 | $44.85 | $3.87 | $11.07 | $9.20 |
| 2015 | $20.54 | $57.18 | $5.95 | $11.71 | $16.09 |
| 2016 | $25.35 | $45.99 | $15.53 | $10.02 | $17.41 |
| 2017 | $30.45 | $79.31 | $3.97 | $7.90 | $3.11 |
| 2018 | $57.16 | $74.30 | $4.79 | $4.52 | $0.00 |
| 2019 | $42.06 | $148.41 | $24.37 | $10.03 | $17.09 |
| 2020 | $38.24 | $49.72 | $2.40 | $8.08 | $0.26 |
| 2021 | $43.89 | $43.44 | $4.63 | $8.40 | $5.68 |
| 2022 | $36.00 | $281.23 | $0.00 | $0.00 | $0.00 |
| 2023 | $34.59 | $218.57 | $0.76 | $4.94 | $0.00 |
| 2024 | $40.00 | $130.16 | $0.00 | $1.17 | $0.00 |
AI valuation
Our deep-learning model estimates Surmodics, Inc.'s (SRDX) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $130.16
- Current price
- —
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$16.12
— upside
Graham-Dodd
$1.17
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| SRDX | Surmodics, Inc. | $27.55 | 393.83M | +373% | -41% | -96% | — | -49.05 | 4.76 | 4.49 | 118.28 | -7.60 | 11.17 | 73.81% | -4.48% | -9.15% | -9.67% | -5.14% | -6.34% | 0.28 | -1.59 | 3.96 | 3.09 | -0.61 | 64545.00% | -491.00% | -14271.00% | -0.57% | 0.01 | -2.95% | 0.00% | 0.00% | 0.00% | -99.07 | -172.40 | 4.44 | 7.30 |
| BVS | Bioventus Inc. | $7.38 | 493.67M | +282% | -50% | — | — | -1890.78 | 4.06 | 1.05 | 22.83 | — | -2.28 | 67.72% | -2.09% | -5.85% | -0.20% | -2.20% | -0.04% | 2.27 | -0.31 | 1.31 | 0.80 | 7.50 | -7912.00% | 1189.00% | 37343.00% | 6.28% | 0.18 | 7.76% | 0.00% | 0.00% | 10.62% | -74.74 | 23.69 | 1.56 | 0.82 |
| CBLL | CeriBell, Inc. | $11.78 | 431.9M | +174% | +614% | — | — | -12.42 | 3.80 | 7.45 | -10.25 | — | 3.82 | 87.89% | -65.57% | -59.97% | -29.21% | -202.59% | -25.36% | 0.14 | -30.90 | 9.73 | 9.08 | 0.33 | -5693.00% | 3609.00% | 1427.00% | -6.27% | -2.13 | -144.22% | 0.00% | 0.00% | 0.00% | -9.04 | -12.70 | 5.93 | 17.63 |
| CCRN | Cross Country Healthcare,… | $13.06 | 427.84M | +276% | -51% | -52% | -20% | -36.53 | 1.27 | 0.40 | 27.06 | — | 2.20 | 20.41% | -1.25% | -1.08% | -3.26% | -3.73% | -2.29% | 0.01 | -7.71 | 2.78 | 2.70 | -4.64 | -12146.00% | -3346.00% | -5250.00% | 20.95% | 1.00 | 27.75% | 0.00% | 0.00% | 19.42% | -26.92 | 4.08 | 0.34 | 5.01 |
| KIDS | OrthoPediatrics Corp. | $16.37 | 410.52M | +286% | -40% | -90% | — | -11.37 | 1.30 | 1.91 | -55.63 | -373.01 | 2.61 | 73.05% | -12.27% | -16.78% | -11.31% | -8.28% | -8.08% | 0.14 | -4.84 | 5.55 | 2.48 | -3.66 | 305.00% | 1545.00% | -6136.00% | -3.54% | -0.11 | -4.56% | 0.00% | 0.00% | 1.84% | -15.12 | -27.47 | 1.85 | 2.35 |
| LAB | Standard BioTools Inc. | $1.14 | 435.47M | +2,511% | -50% | -89% | +600% | -5.60 | 0.99 | 4.92 | -2.77 | — | 0.99 | 49.86% | -109.34% | -87.77% | -16.72% | -23.68% | -12.69% | 0.07 | -3588.65 | 4.19 | 1.86 | 0.92 | -6154.00% | -5108.00% | -4555.00% | -19.69% | -0.69 | -34.48% | 0.00% | 0.00% | 0.00% | -2.82 | -3.18 | 3.08 | 2.09 |
| RXST | RxSight, Inc. | $8.34 | 341.24M | +250% | -42% | -76% | — | — | 1.14 | 2.33 | -2.43 | — | 1.14 | 76.60% | -35.84% | -28.96% | 0.00% | -83.88% | 0.00% | 0.04 | -1204.75 | 10.95 | 9.58 | 0.22 | 3380.00% | -389.00% | -1360.00% | -6.17% | -0.59 | -33.66% | 0.00% | — | 1.44% | -2.00 | -4.98 | 0.72 | 3.16 |
| SMLR | Semler Scientific, Inc. | $28.74 | 425.33M | +198% | +9% | +109% | — | 6.57 | 1.17 | 4.78 | 11.81 | 6.92 | 16.68 | 91.55% | 37.19% | 72.65% | 27.04% | 15.50% | 25.73% | 0.00 | — | 3.59 | 3.06 | -0.41 | 9506.00% | -1744.00% | 1881.00% | 9.06% | 3.87 | 21.12% | 0.00% | 0.00% | 0.00% | 12.13 | 10.43 | 4.51 | 18.96 |
| TCMD | Tactile Systems Technolog… | $24.21 | 540.74M | +159% | +100% | -49% | -31% | — | 3.06 | 2.03 | 16.77 | — | 4.51 | 75.17% | 8.89% | 5.79% | 0.00% | 11.72% | 0.00% | 0.07 | 28.21 | 4.03 | 3.11 | -1.88 | 1714.00% | 1247.00% | 599.00% | 6.03% | 1.05 | 26.58% | 0.00% | — | 6.69% | 20.58 | 14.90 | 1.83 | 9.68 |
| TMCI | Treace Medical Concepts, … | $6.25 | 394.83M | +369% | -89% | — | — | -1.78 | 1.20 | 0.49 | -1.64 | -53.40 | 1.56 | 79.81% | -25.46% | -27.74% | -58.94% | -67.77% | -28.95% | 0.16 | -10.18 | 4.31 | 2.95 | -0.08 | 333.00% | 159.00% | -3953.00% | -28.08% | -0.52 | -36.90% | 0.00% | 0.00% | 52.40% | -1.30 | -2.40 | 0.33 | -0.40 |
| XOMA | XOMA Royalty Corp. | $33.38 | 396.85M | +97% | -54% | — | — | -18.47 | 3.12 | 8.96 | -49.66 | — | 4.56 | 99.28% | -140.33% | -48.52% | -16.20% | -36.44% | -6.07% | 1.46 | -2.89 | 5.15 | 5.01 | -3.24 | -5916.00% | 49872.00% | -2425.00% | -5.39% | -0.56 | -17.69% | 2.14% | -39.60% | 2.15% | -6.74 | -19.56 | 9.45 | -6.65 |
About Surmodics, Inc.
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
- CEO
- Gary R. Maharaj
- Employees
- 389
- Beta
- 1.39
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($16.12 ÷ —) − 1 = — (DCF, example).